C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/54 (2006.01) C12N 9/10 (2006.01) C12N 15/00 (2006.01) C12N 15/30 (2006.01) C12Q 1/18 (2006.01) C12Q 1/68 (2006.01)
Patent
CA 2704070
The present inventors succeeded in isolating GWT1 (PfGWT1), which is one of the enzymes involved in GPI biosynthesis in the malaria parasite P. falciparum. In addition, the inventors revealed that degenerate mutant DNAs, with a lower AT content than the DNA encoding the PfGWT1 protein, can complement the phenotype of GWT1--deficient yeast. Based on the findings, the present invention provides the GWT1 protein of malaria parasites and the use of the protein in methods of screening for antimalarial drugs. The present invention also provides degenerate mutant DNAs encoding proteins involved in GPI biosynthesis, and which have a lower AT content than the original DNAs. The present invention also provides methods of screening for antimalarial drugs which use the degenerate mutant DNAs.
Hata Katsura
Horii Toshihiro
Nakamoto Kazutaka
Ogawa Kaoru
Sagane Koji
Eisai R&d Management Co. Ltd.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Methods of screening for compounds that inhibit the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of screening for compounds that inhibit the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of screening for compounds that inhibit the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1923507